Structure-Based Discovery of the First Inhibitor Targeting the Talin2-β-integrin Interaction with Potent In Vivo Antitumor Activity in Breast Cancer Models
Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 10398-10412
DOI: 10.1021/acs.jmedchem.5c03539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 23.04.2026. Verfasst von Xiaobo Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 2…. Hauptthemen laut MEDLINE: Talin, Breast Neoplasms, Antineoplastic Agents, Peptides. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Changzhou Municipal Science and Technology Bureau, Double First Class University Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
- Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 211198, China.
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- Department of Pathology, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou 213000, China.
- Institute of Translational Medicine, China Pharmaceutical University, Nanjing 211198, China.
ORCID-Profile: Xiaobo Zhang
Förderung
- Changzhou Municipal Science and Technology Bureau
- Double First Class University Plan
- National Natural Science Foundation of China
- Outstanding Youth Program of the Lingang Laboratory
- Basic Research Project of Changzhou Medical Center
Zitieren
APA
Zhang, X., Guan, L., Li, S., Chen, S., Niu, M. M., Lou, M., Zhou, Y., Zhou, Y., & Hu, W. (2026). Structure-Based Discovery of the First Inhibitor Targeting the Talin2-β-integrin Interaction with Potent In Vivo Antitumor Activity in Breast Cancer Models. Journal of Medicinal Chemistry, 69(9), 10398-10412. https://doi.org/10.1021/acs.jmedchem.5c03539
Vancouver
Zhang X, Guan L, Li S, Chen S, Niu MM, Lou M, et al. Structure-Based Discovery of the First Inhibitor Targeting the Talin2-β-integrin Interaction with Potent In Vivo Antitumor Activity in Breast Cancer Models. Journal of Medicinal Chemistry. 2026;69(9):10398-10412. doi:10.1021/acs.jmedchem.5c03539
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaobo and Guan, Lixia and Li, Shuting and Chen, Shutong and Niu, Miao-Miao and Lou, Mengting and Zhou, Yang and Zhou, Yunjiang and Hu, Weiwei},
title = {Structure-Based Discovery of the First Inhibitor Targeting the Talin2-β-integrin Interaction with Potent In Vivo Antitumor Activity in Breast Cancer Models},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {9},
pages = {10398--10412},
doi = {10.1021/acs.jmedchem.5c03539}
}
EUVIMED